Tratamiento con antidepresivos en los trastornos funcionales digestivos

Bixquert, 1995

Erckenbrecht, 1993, Motility disorders of the gastrointestinal tract. Highligths of the 1st European Postraduate Course on Gastrointestinal Motility 10 to 13 June in Utrecht, Z Gastroenterol, 31, 1

Drossman, 1999, Psychosocial aspects of the functional gastrointestinal disorders, Gut, 45, II25, 10.1136/gut.45.2008.ii25

2000

Bonaz, 2003, Visceral sensitivity perturbations integration in the brain-gut axis in functional digestive disorders, J Physiol Pharmacol, 54, 27

Silverman, 1997, Regional cerebral activity in normal and pathological perception of visceral pain, Gastroenterology, 112, 64, 10.1016/S0016-5085(97)70220-8

Villa LF, director. N06A1. Antidepresivos tricíclicos y afines. Medimecum. Guía de Terapia Farmacológica. 9.ª ed. Madrid: Adis Internacional; 2004. p. 664-73.

Raine, 2002, Systematic review of mental and health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?, BMJ, 325, 1082, 10.1136/bmj.325.7372.1082

Ghelardini, 2000, Antinociception induced by amitriptyiline an imipramine is mediated by a2A-adrenoceptors, Jpn J Pharmacol, 82, 130, 10.1254/jjp.82.130

Pasricha, 2003, Approach to the patient with abdominal pain, 781

Castell, 2003, Approach to the patient with unexplained noncardiac chest pain, 692

Bennett, 2001, ABC of the upper gastrointestinal tract. Oesophagus: atypical chest pain and motility disorders, BMJ, 323, 791, 10.1136/bmj.323.7316.791

Peghini, 1998, Imipramine decreases oesophageal pain perception in human male volunteers, Gut, 42, 807, 10.1136/gut.42.6.807

Clouse, 1987, Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial, Gastroenterology, 92, 1027, 10.1016/0016-5085(87)90979-6

Cannon, 1994, Imipramine in patients with chest pain despite normal coronary angiograms, N Engl J Med, 330, 1411, 10.1056/NEJM199405193302003

Prakash, 1999, Long-term outcome from tricyclic antidepressant treatment of functional chest pain, Dig Dis Sci, 44, 2373, 10.1023/A:1026645914933

Grupo de trabajo de la Guía de Práctica Clínica sobre Dispepsia. Manejo del paciente con Dispepsia. Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano. Programa de Elaboración de Guías de Práctica Clínica en Enfermedades Digestivas, desde la Atención Primaria a la Especializada: 3. Barcelona: SCM; 2003.

Tanum, 1996, A new pharmacologic treatment of functional gastrointestinal disorders: a double-blind placebo-controlled study with mianserin, Scand J Gastroenterol, 31, 318, 10.3109/00365529609006404

Mertz, 1998, Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia, Am J Gastroenterol, 93, 160, 10.1111/j.1572-0241.1998.00160.x

Jackson, 2000, Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis, Am J Med, 108, 65, 10.1016/S0002-9343(99)00299-5

Jones, 2003, Evaluation and treatment of dispepsia, Postgrad Med J, 79, 25, 10.1136/pmj.79.927.25

Talley, 2003, Update on the role of drug therapy in non-ulcer dispepsia, Rev Gastroenterol Disord, 3, 25

Delgado-Aros, 2004, Intervenciones psicológicas y antidepresivos en la dispepsia funcional, GH Continuada, 3, 120

Azpiroz, 2001, Tratamiento del dolor abdominal crónico, 417

Jones, 2000, British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome, Gut, 41, 1

Drossman, 2003, Approach to treatment of irritable bowel syndrome

Greenbaum, 1987, Effects of desipramine on irritable bowel syndrome compared with atropine and placebo, Dig Dis Sci, 32, 257, 10.1007/BF01297051

Clouse, 1994, Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience, Aliment Pharmacol Ther, 8, 409, 10.1111/j.1365-2036.1994.tb00308.x

Klein, 1988, Controlled treatment trials in the irritable bowel syndrome, Gastroenterology, 95, 232, 10.1016/0016-5085(88)90319-8

Akehurst, 2001, Treatment of irritable bowel syndrome: a review of randomized clinical trials, Gut, 48, 272, 10.1136/gut.48.2.272

Jailwala, 2000, Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials, Ann Intern Med, 133, 136, 10.7326/0003-4819-133-2-200007180-00013

Coulie, 2000, New therapies for functional bowel diseases, Curr Gastroenterol Rep, 2, 355, 10.1007/s11894-000-0034-8

Clouse, 2003, Therapy Update: Antidepressants for irritable bowel syndrome, Gut, 52, 598, 10.1136/gut.52.4.598

Valenzuela, 2004, Un consenso latinoamericano sobre el síndrome del intestino irritable, Gastroenterol Hepatol, 27, 325, 10.1157/13060695

Moreno, 2003, Tratamiento del síndrome del intestino irritable, Med Clin Monogr (Barc), 4, 41

Creed, 2003, The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome, Gastroenterology, 124, 303, 10.1053/gast.2003.50055

Drossman, 2002, AGA technical review on irritable bowel syndrome, Gastroenterology, 123, 2108, 10.1053/gast.2002.37095

Drossman, 1995, Psychosocial aspects of the functional gastrointestinal disorders, Gastroenterol Int, 8, 47